InnovationRx: Two Industry Veterans Aim To Accelerate The Path To Personalized Care

By Forbes | Sep 11, 2024 at 06:35 PM EST

Highlander Health, founded by former Verily execs, aims to advance personalized healthcare through investments in startups and clinical trial acceleration. Recursion Pharmaceuticals' AI-designed drug REC-994 for cerebral cavernous malformation shows promise in phase 2 trials.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.